Stage‐ and Age‐Specific Survival According to Histological Subtype in Renal Cell Carcinoma: A Nationwide Hospital‐Based Cancer Registry Analysis in Japan
International Journal of Urology · 2026
DOI: 10.1111/iju.70639 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Urology, 2026. Verfasst von Chihiro Kamijo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To clarify stage‐ and age‐specific overall survival (OS) according to histological subtype among surgically treated patients with RCC in Japan, we analyzed a nationwide hospital‐based cancer registry.
Methods
We analyzed data from the Japanese nationwide hospital‐based cancer registry and identified patients newly diagnosed with RCC between 2012 and 2014. Eligible patients underwent surgical treatment and had histologically confirmed clear cell, papillary, or chromophobe RCC with pathological stage (pStage) I–IV according to the UICC TNM classification, 7th edition. Patients treated with radiotherapy or local ablative therapies were excluded. OS was estimated using the Kaplan–Meier method and compared using the log‐rank test.
Results
A total of 17 935 patients met the inclusion criteria, including 15 745 clear cell, 1340 papillary, and 850 chromophobe RCC cases. The 5‐year OS rates for clear cell, papillary, and chromophobe RCC were 91.2%, 89.7%, and 93.5% at pStage I, and declined to 37.5%, 21.7%, and 59.3% at pStage IV, respectively. Age‐stratified analyses in pStage I disease revealed progressively worse OS with advancing age across all histological subtypes. Among patients aged ≥ 85 years, the 5‐year OS rates were 68.2% for clear cell, 50.0% for papillary, and 70.0% for chromophobe RCC.
Conclusions
This nationwide registry‐based study provides updated real‐world evidence on survival patterns in RCC in Japan. Advanced age was associated with reduced OS even in patients with pStage I disease, highlighting the importance of considering age when interpreting overall survival in surgically treated patients with RCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
- Department of Urology and Molecular Oncology, Graduate School of Medicine Dentistry and Health Sciences, Niigata University, Niigata, Japan.
- Department of Urology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
ORCID-Profile: Chihiro Kamijo, Takahiro Osawa, Takuya Moriguchi, Hiroshi Kikuchi, Ryuji Matsumoto, Nobuo Shinohara, Takashige Abe
Zitieren
APA
Kamijo, C., Osawa, T., Moriguchi, T., Miyata, H., Kikuchi, H., Matsumoto, R., Shinohara, N., & Abe, T. (2026). Stage‐ and Age‐Specific Survival According to Histological Subtype in Renal Cell Carcinoma: A Nationwide Hospital‐Based Cancer Registry Analysis in Japan. International Journal of Urology. https://doi.org/10.1111/iju.70639
Vancouver
Kamijo C, Osawa T, Moriguchi T, Miyata H, Kikuchi H, Matsumoto R, et al. Stage‐ and Age‐Specific Survival According to Histological Subtype in Renal Cell Carcinoma: A Nationwide Hospital‐Based Cancer Registry Analysis in Japan. International Journal of Urology. 2026. doi:10.1111/iju.70639
BibTeX
@article{Kamijo2026,
author = {Kamijo, Chihiro and Osawa, Takahiro and Moriguchi, Takuya and Miyata, Haruka and Kikuchi, Hiroshi and Matsumoto, Ryuji and Shinohara, Nobuo and Abe, Takashige},
title = {Stage‐ and Age‐Specific Survival According to Histological Subtype in Renal Cell Carcinoma: A Nationwide Hospital‐Based Cancer Registry Analysis in Japan},
journal = {International Journal of Urology},
year = {2026},
doi = {10.1111/iju.70639}
}
EUVIMED